Exosite-dependent regulation of factor VIIIa by activated protein C

Blood

Volumn 101, Issue 12, 2003, Pages 4802-4807

  Manithody, Chandrashekhara ^b   Fay, Philip J ^b   Rezaie, Alireza R ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ARGININE; BLOOD CLOTTING FACTOR 8A;

ARTICLE; CONTROLLED STUDY; HUMAN; KINETICS; MOLECULAR RECOGNITION; MUTANT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN INTERACTION; REGULATORY MECHANISM;

EID: 0038454577     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-01-0126     Document Type: Article

References (47)

1. Esmon CT. Molecular events that control the protein C anticoagulant pathway. Thromb Haemost. 1993;70:1-5.
2. Walker FJ, Fay PJ. Regulation of blood coagulation by the protein C system. FASEB J. 1992;6:2561-2567.
3. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem. 1994;269:31869-31880.
4. Stenflo J. Structure and function of protein C. Semin Thromb Hemost. 1984;10:109-121.
5. Stenflo J. Structure-function relationships of epidermal growth factor modules in vitamin K-dependent clotting factors. Blood. 1991;78:1637-1651.
6. Mather T, Oganessyan V, Hof P, et al. The 2.8 A crystal structure of Gla-domainless activated protein C. EMBO J. 1996;15:6822-6831.
7. Bode W, Mayr I, Baumann U, Huber R, Stone SR, Hofsteenge J. The refined 1.9 A crystal structure of human α-thrombin: interaction with D-Phe-Pro-Arg chlorometheylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 1989;8:3467-3475.
8. Yang L, Manithody C, Rezaie AR. Contribution of basic residues of the 70-80-loop to heparin binding and anticoagulant function of activated protein C. Biochemistry. 2002;41:6149-6157.
9. Friedrich U, Nicolaes GAF, Villoutreix BO, Dahlbäck B. Secondary substrate-binding exosite in the serine protease domain of activated protein C important for cleavage at Arg-506 but not at Arg-306 in factor Va. J Biol Chem. 2001;276:23105-23108.
10. Gale AJ, Tsavaler A, Griffin JH. Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C. J Biol Chem. 2002;277:28836-28840.
11. Mann KG, Jenny RJ, Krishnaswamy S. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Ann Rev Biochem. 1988;57:915-956.
12. Furie B, Furie BC. The molecular basis of blood coagulation. Cell. 1988;53:505-518.
13. Vehar GA, Davie EW. Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry. 1980;19:401-410.
14. Guinto ER, Esmon CT, Mann KG, MacGillivray RTA. The complete cDNA sequence of bovine coagulation factor V. J Biol Chem. 1992;267:2971-2978.
15. Vehar GA, Keyt B, Eaton D, et al. Structure of human factor VIII. Nature. 1984;312:337-342.
16. Kane WH, Davie EW. Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood. 1988;71:539-555.
17. Lenting PJ, van Mourik JA, Mertens K. The life cycle of coagulation factor VIII in view of its structure and function. Blood. 1998;92:3983-3996.
18. Esmon CT. The subunit structure of thrombin-activated factor V: isolation of activated factor V, separation of subunits and reconstitution of biological activity, J Biol Chem. 1979;254:964-973.
19. Foster WB, Nesheim ME, Mann KG. The factor Xa-catalyzed activation of factor V. J Biol Chem. 1983;258:13970-13977.
20. Lollar P, Fay PJ, Fass DN. Factor VIII and factor VIIIa. Methods Enzymol. 1993;222:128-143.
21. Eaton D, Rodriguez H, Vehar GA. Proteolytic processing of human factor VIII: correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. Biochemistry. 1986;25:505-512.
22. Fay PJ, Smudzin TM. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa. J Biol Chem. 1992;267:13246-13250.
23. Nicolaes GAF, Dahlbäck B, Factor V and thrombotic diseases: description of a Janus-faced protein. Arterioscler Thromb Vasc Biol. 2002;22:530-538.
24. R506Q by activated protein C. J Biol Chem. 1995;270:27852-27858.
25. a. J Biol Chem. 1991;266:20139-20145.
26. Regan LM, Lamphear BJ, Huggins CF, Walker FJ, Fay PJ. Factor IXa protects factor Villa from activated protein C. J Biol Chem. 1994;269:9445-9452.
27. O'Brien LM, Mastri M, Fay PJ. Regulation of factor Villa by human activated protein C and protein S: inactivation of cofactor in the intrinsic factor Xase. Blood. 2000;95:1714-1720.
28. Rezaie AR. Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1: Implications for the mechanism of profibrinolytic action of activated protein C. J Biol Chem. 2001;276:15567-15570.
29. Curtis JE, Helgerson SL, Parker ET, Lollar P. Isolation and characterization of thrombin-activated human factor VIII. J Biol Chem. 1994;269:6246-6251.
30. Lapan KA, Fay PJ. Localization of a factor X interactive site in the A1 subunit of factor VIIIa. J Biol Chem. 1997;272:2082-2088.
31. Koszelak ME, Schmidt K, Freas J, Mastri M, Fay PJ. Cofactor activities of factor VIIIa and A2 subunit following cleavage of A1 subunit at Arg336. J Biol Chem. 2002;277:11664-11669.
32. Manithody C, Yang L, Rezaie AR. Role of basic residues of the autolysis loop in the catalytic function of factor Xa. Biochemistry. 2002;41:6780-6788.
33. Rezaie AR. Tryptophan60-D in the B-insertion loop of thrombin modulates the thrombin-antithrombin reaction. Biochemistry. 1996;35:1918-1924.
34. Smirnov MD, Esmon CT. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J Biol Chem. 1994;269:816-819.
35. Kisiel W, Davie EW. Protein C. Methods Enzymol. 1981;80:320-332.
36. Shen L, Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem. 1994;269:18735-18738.
37. Mann KG, Hockin MF, Begin KJ, Kalafatis M. Activated protein C cleavage of factor Va leads to dissociation of the A2 domain. J Biol Chem. 1997;272:20678-20683.
38. Walker FJ, Scandella D, Fay PJ. Identification of the binding site for activated protein C on the light chain of factors V and VIII. J Biol Chem. 1990;265:1484-1489,
39. Stoilova-McPhie S, Villoutreix BO, Mertens K, Kemball-Cook G, Holzenburg A. 3-dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography. Blood. 2002;99:1215-1223.
40. Nogami K, Wakabayashi H, Schmidt K, Fay PJ. Altered interaction between the A1 and A2 subunits of factor Villa following cleavage of A1 subunit by factor Xa. J Biol Chem. 2003;278:1634-1641.
41. Bajaj SP, Schmidt AE, Mathur A, Padmanabhan K, Mastri M, Fay PJ. Factor IXa:factor VIIIa interaction: helix 330-338 of factor IXa interacts with residues 558-565 and spatially adjacent region of the A2 subunit of factor VIIIa. J Biol Chem. 2001;276:16302-16309.
42. Fay PJ, Beattie T, Huggins CF, Regan LM. Factor Villa A2 subunit residues 558-565 represent a factor IXa interactive site. J Biol Chem. 1994;269:20522-20527.
43. Gruber A, Griffin JH. Direct detection of activated protein C in blood from human subjects. Blood. 1992;79:2340-2348.
44. Castellino FJ. Human protein C and activated protein C: components of the human anticoagulation system. Trends Cardiovasc Med. 1995;5:55-62.
45. Madison EL, Goldsmith EJ, Gerard RD, Gething M-JH, Sambrook JF, Bassel-Duby RS. Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1. Proc Natl Acad Sci U S A. 1990;87:3530-3533.
46. Rezaie AR, Esmon CT. Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors. J Biol Chem. 1993;268:19943-19948.
47. Esmon CT, Lollar P. Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII. J Biol Chem. 1996;271:13882-13887.